Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPAR alpha.
Lee
S S
SS
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Gonzalez
F J
FJ
D000818:Animals; D002273:Carcinogens; D002994:Clofibrate / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology; D051379:Mice; D018345:Mice, Knockout; D008830:Microbodies / Q000201:enzymology*; D016254:Mutagenesis, Insertional; D011743:Pyrimidines / Q000494:pharmacology; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*
D002273:Carcinogens; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D011743:Pyrimidines; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; C006253:pirinixic acid; D002994:Clofibrate